Institution

The Netherlands Cancer Institute

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 2 TRIAL

RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an unstarted Phase 2 interventional trial with no posted results; it is a study design and rationale only, representing early-stage exploration of immunotherapy monotherapy in a selected population.

PreliminaryNCT07808138 Immunotherapy The Netherlands Cancer Institute

Reported

Planned enrollment30

PhasePhase 2

Primary outcome measureRecurrence-free survival (RFS) as per RECIS…

AUG 11, 2026 · PHASE 1 TRIAL

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

ClinicalTrials.gov

Phase 1 diagnostic imaging study in early recruitment with no results posted; designed to assess tracer accumulation and feasibility of detecting HER2 phenotype differences.

PreliminaryHER2 Expression Blood sampling for pharmacokinetics PET imaging with ⁸⁹Zr-trastuzumab

Reported

Planned enrollment20

PhasePhase 1

Primary outcome measureStandard uptake values (SUVs) in tumor lesi…